标题
Immune checkpoint inhibitors for cancer and venous thromboembolic events
作者
关键词
Immune checkpoint inhibitors, Venous thromboembolism, Cardio-oncology, Anticoagulation, Cancer, Vascular medicine
出版物
EUROPEAN JOURNAL OF CANCER
Volume 158, Issue -, Pages 99-110
出版商
Elsevier BV
发表日期
2021-10-16
DOI
10.1016/j.ejca.2021.09.010
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival
- (2021) Tamara A Sussman et al. Journal for ImmunoTherapy of Cancer
- Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
- (2020) Lili Zhang et al. EUROPEAN HEART JOURNAL
- Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis
- (2020) Magid Awadalla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Neoadjuvant checkpoint blockade for cancer immunotherapy
- (2020) Suzanne L. Topalian et al. SCIENCE
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis
- (2020) Lili Zhang et al. CIRCULATION
- Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque
- (2020) Zsofia D. Drobni et al. CIRCULATION
- Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review
- (2020) Cinzia Solinas et al. THROMBOSIS RESEARCH
- Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
- (2019) Magid Awadalla et al. Journal for ImmunoTherapy of Cancer
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
- (2019) Vicky Makker et al. LANCET ONCOLOGY
- Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study
- (2019) Jair Bar et al. EUROPEAN JOURNAL OF CANCER
- Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors
- (2019) Yosuke Ando et al. INVESTIGATIONAL NEW DRUGS
- Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients
- (2019) Federico Nichetti et al. Cancers
- Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient
- (2018) Yuko Horio et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pembrolizumab-induced acute thrombosis
- (2018) Kei Kunimasa et al. MEDICINE
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
- (2016) Howard L Kaufman et al. LANCET ONCOLOGY
- Evaluating efficiency and statistical power of self-controlled case series and self-controlled risk interval designs in vaccine safety
- (2015) Rongxia Li et al. Journal of Biopharmaceutical Statistics
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More